Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1989-05-19
1990-04-17
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
534 14, A61K 4902, C07F 1300
Patent
active
049178792
ABSTRACT:
A myocardial imaging agent for humans is a technetium(III) complex ligated in the planar positions by a tetradentate ligand such as (acac).sub.2 en and in the axial positions by an ether containing phosphine ligand such as tris(3-methoxy-1-propyl)phosphine. The agent exhibits extremely rapid blood clearance after injection into a human and has a sufficiently high heart/liver and heart/lung ratios to provide effective myocardial images.
REFERENCES:
patent: 4758682 (1988-07-01), Collins et al.
patent: 4795626 (1989-01-01), Deutsch et al.
Deutsch et al., "Development of Non-Reducible Technetium 99m(III) Cations . . . ", J. Nucl. Medicine, 28: 1870-1880, 1987.
Kelly et al: J. Nucl. Med., vol. 30, No. 5, p. 773, May, 1989.
Lahiri et al: J. Nucl. Med. 1987, 28:721.
Kelly et al: J. Nucl. Med., vol. 30, No. 5, p. 773, May, 1989.
Lahiri et al: J. Nucl. Med. 1987, 28:721.
Deutsch Edward A.
Libson Karen F.
Maples John S.
University of Cincinnati
LandOfFree
99MTC(III) myocardial imaging agents that are effective in human does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 99MTC(III) myocardial imaging agents that are effective in human, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 99MTC(III) myocardial imaging agents that are effective in human will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1051336